CNMD CONMED Corporation

$55.81

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Updated On 8/22/2025

About CONMED Corporation

CONMED Corporation, a medical technology company, develops, manufactures and sells surgical devices and related equipment for minimally invasive procedures worldwide. The company is headquartered in Largo, Florida.

Website: https://www.conmed.com

Sector
LIFE SCIENCES
Industry
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
816956
Address
525 FRENCH ROAD, UTICA, NY, US
Valuation
Market Cap
$1.50B
P/E Ratio
11.43
PEG Ratio
5.29
Price to Book
1.56
Performance
EPS
$4.25
Dividend Yield
1.65%
Profit Margin
10.10%
ROE
14.70%
Technicals
50D MA
$59.27
200D MA
$67.37
52W High
$77.67
52W Low
$47.25
Fundamentals
Shares Outstanding
31M
Target Price
$77.29
Beta
1.29

CNMD EPS Estimates vs Actual

Estimated
Actual

CNMD News & Sentiment

Aug 22, 2025 • Zacks Commentary BULLISH
Here's Why Conmed ( CNMD ) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Aug 12, 2025 • Zacks Commentary BULLISH
Why Conmed ( CNMD ) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Aug 06, 2025 • Zacks Commentary BULLISH
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Aug 05, 2025 • Zacks Commentary BULLISH
Why Conmed ( CNMD ) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Jul 31, 2025 • Motley Fool SOMEWHAT-BULLISH
Conmed ( CNMD ) Q2 EPS Jumps 17%
Conmed ( NYSE:CNMD ) , a medical technology company specializing in surgical devices, reported its financial results on July 30, 2025. The headline news from the release was that both GAAP revenue and adjusted earnings per share ( non-GAAP ) topped analyst projections, with GAAP revenue reaching ...
Jul 31, 2025 • Zacks Commentary SOMEWHAT-BULLISH
CONMED Q2 Earnings & Revenues Beat Estimates, 2025 Outlook Raised
CNMD reports solid second-quarter results, driven by improving sales across both segments.
Sentiment Snapshot

Average Sentiment Score:

0.216
50 articles with scored sentiment

Overall Sentiment:

Bullish

CNMD Reported Earnings

Apr 22, 2025
Mar 31, 2025 (Post market)
0.14 Surprise
  • Reported EPS: $0.95
  • Estimate: $0.81
  • Whisper:
  • Surprise %: 17.1%
Jan 29, 2025
Dec 31, 2024 (Pre market)
0.14 Surprise
  • Reported EPS: $1.34
  • Estimate: $1.20
  • Whisper:
  • Surprise %: 11.4%
Oct 30, 2024
Sep 30, 2024 (Post market)
0.06 Surprise
  • Reported EPS: $1.05
  • Estimate: $0.99
  • Whisper:
  • Surprise %: 6.1%
Jul 31, 2024
Jun 30, 2024 (Post market)
0.07 Surprise
  • Reported EPS: $0.98
  • Estimate: $0.91
  • Whisper:
  • Surprise %: 7.7%
Apr 24, 2024
Mar 31, 2024 (Post market)
0.05 Surprise
  • Reported EPS: $0.79
  • Estimate: $0.74
  • Whisper:
  • Surprise %: 6.8%
Jan 08, 2024
Dec 31, 2023 (Pre market)
-0.05 Surprise
  • Reported EPS: $1.06
  • Estimate: $1.11
  • Whisper:
  • Surprise %: -4.5%
Oct 25, 2023
Sep 30, 2023 (Post market)
0.07 Surprise
  • Reported EPS: $0.90
  • Estimate: $0.83
  • Whisper:
  • Surprise %: 8.4%
Jul 26, 2023
Jun 30, 2023 (Post market)
0.04 Surprise
  • Reported EPS: $0.83
  • Estimate: $0.79
  • Whisper:
  • Surprise %: 5.1%
Apr 26, 2023
Mar 31, 2023 (Post market)
0.06 Surprise
  • Reported EPS: $0.66
  • Estimate: $0.60
  • Whisper:
  • Surprise %: 10.0%

Financials